Smyth JF - Search Results

1

Processing of [D-Arg1,D-Phe5,D-Trp7,9,Leu11]substance P in xenograft bearing Nu/Nu mice.

Jones DA, MacLellan AJ, Cummings J, Ritchie AA, Langdon SP, Smyth JF. Jones DA, et al. Among authors: smyth jf. Peptides. 1997;18(7):1073-7. doi: 10.1016/s0196-9781(97)00042-9. Peptides. 1997. PMID: 9357069

2

Broad spectrum neuropeptide antagonists inhibit the growth of small cell lung cancer in vivo.

Langdon S, Sethi T, Ritchie A, Muir M, Smyth J, Rozengurt E. Langdon S, et al. Cancer Res. 1992 Aug 15;52(16):4554-7. Cancer Res. 1992. PMID: 1379515

3

Growth inhibition of oestrogen receptor-positive human ovarian carcinoma by anti-oestrogens in vitro and in a xenograft model.

Langdon SP, Crew AJ, Ritchie AA, Muir M, Wakeling A, Smyth JF, Miller WR. Langdon SP, et al. Among authors: smyth jf. Eur J Cancer. 1994;30A(5):682-6. doi: 10.1016/0959-8049(94)90545-2. Eur J Cancer. 1994. PMID: 8080688

4

Pharmacokinetics, metabolism, tissue and tumour distribution of the neuropeptide growth factor antagonist [Arg6, D-Trp7,9, NmePhe8]- substance P(6-11) in nude mice bearing the H69 small-cell lung cancer xenograft.

Cummings J, MacLellan AJ, Jones DA, Langdon SP, Rozengurt E, Ritchie AA, Smyth JF. Cummings J, et al. Among authors: smyth jf. Ann Oncol. 1995 Jul;6(6):595-602. doi: 10.1093/oxfordjournals.annonc.a059250. Ann Oncol. 1995. PMID: 8573540 Free article.

5

Metabolism of the broad-spectrum neuropeptide growth factor antagonist: [D-Arg1, D-Phe5, D-Trp7,9, Leu11]-substance P.

Jones DA, Cummings J, Langdon SP, Maclellan AJ, Higgins T, Rozengurt E, Smyth JF. Jones DA, et al. Among authors: smyth jf. Br J Cancer. 1996 Mar;73(6):715-20. doi: 10.1038/bjc.1996.126. Br J Cancer. 1996. PMID: 8611370 Free PMC article.

6

Preclinical studies on the broad-spectrum neuropeptide growth factor antagonist G.

Jones DA, Cummings J, Langdon SP, Smyth JF. Jones DA, et al. Among authors: smyth jf. Gen Pharmacol. 1997 Feb;28(2):183-9. doi: 10.1016/s0306-3623(96)00189-9. Gen Pharmacol. 1997. PMID: 9013192 Review.

7

Metabolism of the anticancer peptide H-Arg-D-Trp-NmePhe-D-Trp-Leu-Met-NH2.

Jones DA, Cummings J, Langdon SP, MacLellan AJ, Higgins T, Rozengurt E, Smyth JF. Jones DA, et al. Among authors: smyth jf. Peptides. 1995;16(5):777-83. doi: 10.1016/0196-9781(95)00048-o. Peptides. 1995. PMID: 7479315

8

Determination of two neuropeptide growth factor antagonists, [D-Arg1,D-Phe5,D-Trp7,9,Leu11]-substance P and [Arg6,D-Trp7,9,N-MePhe8]- substance P(6-11), by high-performance liquid chromatography with electrochemical detection.

Cummings J, MacLellan A, Langdon SP, Rozengurt E, Smyth JF. Cummings J, et al. Among authors: smyth jf. J Chromatogr B Biomed Appl. 1994 Mar 4;653(2):195-203. doi: 10.1016/0378-4347(93)e0442-s. J Chromatogr B Biomed Appl. 1994. PMID: 7515751

9

Stability and in vitro metabolism of the mitogenic neuropeptide antagonists [D-Arg1,D-Phe5, D-Trp7,9, Leu11]-substance P and [Arg6, D-Trp7,9, MePhe8]-substance P (6-11) characterized by high-performance liquid chromatography.

Cummings J, MacLellan A, Langdon SP, Smyth JF. Cummings J, et al. Among authors: smyth jf. J Pharm Biomed Anal. 1994 Jun;12(6):811-9. doi: 10.1016/0731-7085(93)e0027-k. J Pharm Biomed Anal. 1994. PMID: 7522585

10

Processing of the neuropeptide growth factor antagonist [Arg6, D-Trp7.9, NmePhe8]-substance P (6-11) by a small cell lung cancer cell line (H69).

Cummings J, MacLellan AJ, Langdon SP, Jones DA, Rozengurt E, Smyth JF. Cummings J, et al. Among authors: smyth jf. Biochem Pharmacol. 1995 May 26;49(11):1709-12. doi: 10.1016/0006-2952(95)00074-a. Biochem Pharmacol. 1995. PMID: 7540393

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

287 results

Search Page

Filters